Stock CHRS COHERUS BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Coherus BioSciences, Inc.

Equities

CHRS

US19249H1032

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-07-16 pm EDT 		5-day change 1st Jan Change
1.8 USD +9.09% Intraday chart for Coherus BioSciences, Inc. +24.14% -45.95%
Jul. 15 Hanall Biopharma Co., Ltd. Appoints Christopher W Slavinsky as Chief Business Development and Legal Officer CI
Jul. 02 Coherus BioSciences Grants Apotex License to Distribute Toripalimab in Canada MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
COHERUS BIOSCIENCES, INC. Stock Coherus BioSciences, Inc.
 189M -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 127B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 117B
ARGENX SE Stock argenx SE
 27.67B -
BIONTECH SE Stock BioNTech SE
 20.33B -
GENMAB A/S Stock Genmab A/S
 16.79B
  1. Stock Market
  2. Equities
  3. CHRS Stock
  4. Charts Coherus BioSciences, Inc.
  5. Sector Chart